Upcoming 2024 Gastric Cancer Summit
2024 Gastric Cancer Summit
Gastric cancer is the third leading cause of cancer death worldwide and is diagnosed in 27,000 Americans each year. In the United States, this burden falls disproportionately on ethnic minorities and immigrant communities, especially Asians. There exists no coherent national strategy for the early detection or risk attenuation of gastric cancer, even among identified high-risk groups. The under-recognition of gastric cancer risk among minority communities is the most significantly unaddressed healthcare disparity issue in the United States. This summit aims to foster a global dialogue on reducing morbidity and mortality from gastric cancer, especially among vulnerable populations.
The 2024 Gastric Cancer Summit took place at Stanford University on November 7-8, 2024. This in-person summit gathered physicians, researchers, policy makers, patients, and advocacy groups from around the world to address the pressing issue of gastric cancer.
Hosted by the Stanford Center for Asian Health Research and Education (CARE), this multidisciplinary event aimed to build upon the foundation laid in previous summits, working towards tangible solutions and a roadmap for addressing healthcare disparities in gastric cancer.
Together, we can improve early detection, prevention and healthcare outcomes for all affected by gastric cancer. To view the details of what was discussed during the 2024 Gastric Cancer Summit, please see below.
November 7, 2024
| 7:30 | 8:30 | Welcome Breakfast | |
| 8:30 | 8:40 | Introductory Remarks | Joo Ha Hwang, Stanford University |
| 8:40 | 9:00 | Personal reflections on Gastric Cancer | Michael Kim and Lauren Kim |
| Day 1, Session 1: Gastric Cancer – Why should we CARE? | Moderators: Chin Hur, Columbia University; Hwoon-yong Jung, Asan Medical Center | ||
| 9:00 | 9:15 | Incidence of gastric cancer – globally and in the US | Shailja Shah, UCSD/San Diego VA |
| 9:15 | 9:30 | Global Efforts for the Prevention of Gastric Cancer | Jin Young Park, IARC, WHO |
| 9:30 | 9:45 | Efficacy of Gastric Cancer Screening Programs in Asia | Il Ju Choi, National Cancer Center, Korea |
| 9:45 | 10:00 | Endoscopic resection and outcomes | Naohisa Yahigi, Keio University |
| 10:00 | 10:15 | Panel Discussion | |
| 10:15 | 10:30 | Break | |
| Day 1, Session 2: Gastric Cancer – How does it develop? | Moderators: Scott Kuwada, University of Hawaii, Dan Li, Kaiser Permanente | ||
| 10:30 | 10:45 | H. pylori: a historical perspective on its association with cancer | Julie Parsonnet, Stanford University |
| 10:45 | 11:00 | Gastric intestinal metaplasia as a precursor to cancer | Robert Huang, Stanford University |
| 11:00 | 11:15 | Endoscopic screening for gastric precancerous lesions | Fabian Emura, University of Miami |
| 11:15 | 11:30 | Panel Discussion | |
| Day 1, Session 3: Improving outcomes in the US – The need for primary and secondary prevention of Gastric Cancer | Moderators: Meira Epplein, Duke University; Robert Huang, Stanford University | ||
| 11:30 | 11:45 | Primary prevention of gastric cancer – treating h pylori | Paul Moayyedi, McMaster University |
| 11:45 | 12:00 | Secondary prevention - Gastric cancer screening in the US – Who and how? | Joo Ha Hwang, Stanford University |
| 12:00 | 12:15 | Gastric cancer prevention: the Kaiser experience | Daniel Li, Kaiser Permanente |
| 12:15 | 12:30 | Panel Discussion | |
| 12:30 | 1:30 | Lunch Break | |
| Day 1, Session 4: Societal Guidelines | Moderators: John Inadomi, University of Utah; Joo Ha Hwang, Stanford University | ||
| 1:30 | 1:50 | European guidelines on precancerous lesions | Ernst J. Kuipers, Nanyang Technological University, Singapore |
| 1:50 | 2:10 | AGA Guidance on screening for gastric cancer and surveillance of precancerous lesions | Andrew Wang, University of Virginia |
| 2:10 | 2:40 | Three recent ACG Guidelines: Synergy and Potential Impact on Gastric Cancer in the U.S. | Doug Morgan, University of Alabama - Birmingham |
| 2:40 | 3:00 | Panel Discussion | |
| 3:00 | 3:15 | Remarks from the Dean | Dean Lloyd Minor |
| 3:15 | 3:30 | Break | Video Remarks: CAPAC Chair Representative Judy Chu (CA), Representative Yadira Caraveo M.D. (CO), Anabella Aspiras, The White House Cancer Moonshot |
| Day 1, Session 5: Advancing health policy for the prevention of gastric cancer in the US – A panel discussion | Moderator Panel 1: Yanghee Woo, City of Hope Moderator Panel 2: Joo Ha Hawng, Stanford University | ||
| 3:30 | 5:00 | Panel 1: Federal Policy Updates Panel 2: Private Policy Advancements: Kaiser Permanente Advancements in Clinical Policies and Protocols | Panel 1 Panelists: Aki Smith, Hope for Stomach Cancer, Kathy Ko Chin, Jasper Inclusion Advisors Panel 2 Panelists: Jeff Fox, Kaiser Permanente; Scott Kuwada, University of Hawaii; Bechien Wu, Southern California Permanente Medical Group |
November 8, 2024
| 8:00 | 8:30 | Breakfast | |
| 8:30 | 8:40 | Introductions | Robert Huang, Stanford University |
| Day 2, Scientific Session 1: Scientific advances in the interception of gastric cancer. | Moderators: Robert Huang, Stanford University; Shailja Shah, UCSD | ||
| 8:40 | 9:00 | The ECHOS cohort | Arnoldo Riquelme, Pontificia Universidad Catolica de Chile |
| 9:00 | 9:20 | Early detection and interception of diffuse and intestinal gastric cancer | Andrew Chan, Harvard University |
| 9:20 | 9:40 | Preliminary experience with community-based EGD screening | Haejin In, Rutgers University |
| 9:40 | 10:00 | Gastric cancer CISNET modeling: an update | Chin Hur, Columbia University |
| 10:00 | 10:15 | Panel discussion | |
| 10:15 | 10:30 | Break | |
| Day 2, Scientific Session 2: Screening and eradication of H. pylori: an opportunity for prevention | Moderators: Joo Ha Hwang, Stanford University; Khay Guan Yeoh, National University of Singapore | ||
| 10:30 | 10:50 | Community based testing and treatment for H. pylori | Shria Kumar, University of Miami |
| 10:50 | 11:10 | Gastric cancer among the US-born and foreign-born immigrants in the US. | Eunjung Lee, University of Southern California |
| 11:10 | 11:30 | Using artificial intelligence to improve the recognition of gastric neoplasia | Yutaka Tomizawa, University of Washington |
| 11:30 | 11:45 | The Linqu H. pylori eradication trial | Markus Gerhard, Technical University of Munich |
| 11:45 | 12:00 | Panel discussion | |
| 12:00 | 12:40 | Lunch break | |
| Day 2, Session 3: Discovering impactful biomarkers to improve gastric cancer prevention | Moderators: Markus Gerhard, Technical University of Munich; Haejin In, Rutgers University | ||
| 12:40 | 1:00 | Intercepting gastric cancer in the US: CagA as a predictor of risk | Meira Epplein, Duke University |
| 1:00 | 1:20 | Insights from the Singaporean GCEP programme | Khay Guan Yeoh, National University of Singapore |
| 1:20 | 1:40 | Histologic interpretation of gastric intestinal metaplasia | Blanca Piazuelo, Vanderbilt University |
| 1:40 | 2:00 | Biomarker for Gastric Cancer: where are we and where are we going? | Constanza Camargo, National Cancer Institute |
| 2:00 | 2:15 | Panel discussion | |
| 2:15 | 2:30 | Break | |
| Day 2, Closing Session – Priorities and Future Directions – A Panel Discussion | Moderators: Joo Ha Hwang, Stanford University; Robert Huang, Stanford University | ||
| 2:30 | 3:30 | Panelists: Asad Umar, National Cancer Institute; Douglas Morgan, UAB; Jin Young Park, IARC | |
| 3:30 | 3:45 | Closing remarks, group photos | |
| 4:00 | 5:00 | Wine and Cheese Reception | |
Planning Committee Members
Speakers and Moderators:
Meet the 2024 Gastric Cancer Summit speakers and moderators below, organized alphabetically by last name.
We are deeply grateful to the Fortinet Founders for their generous support in sponsoring the 2024 Gastric Cancer Summit. Their commitment has made this critical event possible, enabling us to advance important conversations and solutions around gastric cancer prevention and treatment.